Importantly, AHRhigh/ALDHhigh breast cancer CSCs were significantly more efficient at initiating tumors than AHRlow/ALDHlow cells, and AHR knockdown with siRNA significantly reduced tumor-initiating capacity [162], a sine qua non of CSCs [207]. The gene discussed is AHR; the disease is breast carcinoma.